Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Inhibition of DNA synthesis is a therapeutic strategy that blocks cellular or viral DNA replication by interfering with key enzymes or substrates required for DNA strand formation and elongation. This approach is widely used in antimicrobial, antiviral, and anticancer therapies to halt the growth of rapidly dividing cells.
Inhibition of enzymes (e.g., topoisomerases, DNA polymerases, ribonucleotide reductase) or disruption of DNA structure, leading to cessation of DNA replication.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Inhibition of DNA Synthesis.